Matthew Plunkett Insider Trading for September 2015

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew Plunkett.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Overview of insider trading of Matthew Plunkett for September 2015.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.61	660	1,063	725,084	725.7 K to 725.1 K (-0.09 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.61	1,390	2,231	725,744	727.1 K to 725.7 K (-0.19 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.60	14,400	23,040	727,134	741.5 K to 727.1 K (-1.94 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.60	1,500	2,393	741,534	743 K to 741.5 K (-0.20 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.59	16,400	26,076	743,034	759.4 K to 743 K (-2.16 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.59	7,000	11,095	759,434	766.4 K to 759.4 K (-0.91 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.58	5,330	8,421	766,434	771.8 K to 766.4 K (-0.69 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.58	1,000	1,575	771,764	772.8 K to 771.8 K (-0.13 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.57	1,700	2,669	772,764	774.5 K to 772.8 K (-0.22 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.56	800	1,248	774,464	775.3 K to 774.5 K (-0.10 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	800	1,240	775,264	776.1 K to 775.3 K (-0.10 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	600	927	776,064	776.7 K to 776.1 K (-0.08 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	289	445	776,664	777 K to 776.7 K (-0.04 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	100	154	776,953	777.1 K to 777 K (-0.01 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	6,899	10,555	777,053	784 K to 777.1 K (-0.88 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	200	306	783,952	784.2 K to 784 K (-0.03 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	13,201	20,132	784,152	797.4 K to 784.2 K (-1.66 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.52	3,600	5,472	797,353	801 K to 797.4 K (-0.45 %)
Sep 23 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Grant	A	0.00	151,739	0	800,953	649.2 K to 801 K (+23.37 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	1,800	2,790	649,214	651 K to 649.2 K (-0.28 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	1,000	1,540	651,014	652 K to 651 K (-0.15 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	1,700	2,610	652,014	653.7 K to 652 K (-0.26 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	5,500	8,415	653,714	659.2 K to 653.7 K (-0.83 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Payment of Exercise	F	1.52	12,526	19,040	659,214	671.7 K to 659.2 K (-1.86 %)